Dragon Pharma’s NPP 150 (Nandrolone Phenylpropionate) is a fast-acting injectable compound known for its precise dosing and consistent batch quality. As part of the Dragon Pharma injectable lineup, this product is manufactured with a focus on maintaining stable concentrations across production batches.
Below are independent lab reports verifying the potency of NPP 150, tested by a trusted third-party laboratory.
Latest Lab Results
1. Janoshik Lab Report – 2026-03-23
- Product: NPP 150
- Active Substance: Nandrolone Phenylpropionate
- Labeled Dosage: 150 mg/mL
- Result: 151.82 mg/mL
- Laboratory: Janoshik
This recent lab test shows a measured concentration of 151.82 mg/mL, which is extremely close to the labeled 150 mg/mL dosage, indicating high formulation accuracy.
Previous Lab Result
2. Janoshik Lab Report – 2024-05-16
- Result: 149.43 mg/mL
- Overview: This earlier lab test showed a concentration of 149.43 mg/mL, which is also extremely close to the labeled dosage and confirms consistent batch performance over time.
Potency Consistency Analysis
Across both available lab reports, Dragon Pharma NPP 150 demonstrates extremely tight dosing accuracy, with results remaining very close to the labeled 150 mg/mL concentration.
- Labeled dosage: 150 mg/mL
- Tested range: 149.43–151.82 mg/mL
- Deviation: Within ±1.5%
- Laboratory: Janoshik
This narrow variation range indicates a high level of manufacturing precision and reliable batch-to-batch consistency.
About NPP (Nandrolone Phenylpropionate)
Nandrolone Phenylpropionate (NPP) is a fast-acting ester of nandrolone, commonly used in injectable formulations where stable dosing and predictable release are important. Due to its shorter ester, accurate concentration is essential for maintaining consistent effects.
Independent lab testing plays a key role in verifying that each batch meets expected standards, particularly for compounds requiring precise dosing.
Conclusion
Independent lab reports from 2024 and 2026 confirm that Dragon Pharma NPP 150 consistently delivers concentrations very close to its labeled 150 mg/mL dosage. With results ranging from 149.43 mg/mL to 151.82 mg/mL, the product demonstrates excellent formulation accuracy.
This level of consistency across multiple batches highlights strong manufacturing control and reinforces the reliability of Dragon Pharma NPP 150.
Frequently Asked Questions
Yes, lab results show values extremely close to the labeled 150 mg/mL dosage, with minimal deviation.
Available lab reports show a range between 149.43 mg/mL and 151.82 mg/mL, indicating highly accurate dosing.
Both available lab reports were conducted by Janoshik, an independent laboratory known for steroid analysis.
Yes, the two lab reports from different years show nearly identical concentrations, confirming strong batch consistency.
